You are in free guest mode.
Timed Practice
Revision List
Attempt History
Progress Tracking
Create a free account to unlock these tools
LanguageCert Practice Listening: Part 4 (Extended Listening)
ID: #55707
Easy
Pricing and Access
Instructions
You will hear part of a University Tutorial about pricing and access. You will hear the discussion twice. Choose the correct answers. You have one minute to read through the questions.
Transcript:
R: Listening Part Four.
R: You will hear part of a University Tutorial about pricing and access.
R: You will hear the discussion twice. Choose the correct answers. You have one minute to read through the questions below.
[beep]
Host: Good afternoon, everyone. In today’s tutorial we’re looking at pricing and access in public health, specifically how the cost of medicines and services affects who actually receives care. With me are Dr Alex Romero, a health economist, and Dr Lila Chen, who works on health equity. I’d like us to explore not only prices themselves, but also the broader impact on access. Alex, could you start us off with your initial view?
Male Expert: Thanks, Helen. I think it’s useful to begin by saying that pricing is not just about profit. From an economic point of view, prices can signal value and help ensure a stable supply. If prices are pushed too low without planning, we may see shortages or reduced innovation. That said, I do accept that high prices can limit access, especially for low-income groups, so the challenge is finding a balance rather than assuming lower prices always solve the problem.
Female Expert: I agree that balance is important, but I’d frame the issue slightly differently. From an equity perspective, the starting point is access. If people can’t afford essential medicines or basic services, the system is failing in its public health role. In many settings, prices are already a barrier, even when supply exists. So while I understand Alex’s concern about sustainability, I think affordability has to come first in policy decisions.
Host: That’s a helpful contrast. Let us move on to the role of governments. Many governments use subsidies or price controls to improve access. Alex, how effective do you think these tools are in practice?
Male Expert: In my view, subsidies can be effective if they’re well targeted. For example, supporting low-income patients directly can improve access without distorting the entire market. Price controls, on the other hand, are more risky. They can work in the short term, but over time they may discourage manufacturers from entering the market. I’m not saying they should never be used, but I’d be cautious and use them alongside other measures.
Female Expert: Can I add to that? I think the evidence shows that carefully designed price regulation doesn’t automatically lead to shortages. In some countries, negotiated pricing has expanded access quite successfully. That may be true, Alex, that poor design causes problems, but the same can be said of subsidies. If subsidies are too complex, the people who need them most may not benefit.
Host: So there seems to be some agreement that design matters. I’d like to pick up on something implicit here: the difference between theoretical outcomes and real-world behaviour. Lila, do you think economic models underestimate social factors?
Female Expert: To some extent, yes. Models are useful, but they don’t always capture how people experience costs. For example, even small fees can discourage care if people are uncertain about future expenses. So when we talk about ‘affordable’, it’s not only the absolute price, but also predictability and trust in the system.
Male Expert: That’s a good point, and I don’t disagree. I’d just add that ignoring costs entirely can also harm trust. If a system becomes financially unstable, patients may lose confidence in its long-term availability. So again, I see this as a trade-off rather than a choice between economics and equity.
Host: We’re coming towards the end, so let me ask one final question. If you had to prioritise one principle for policymakers working on pricing and access, what would it be? Lila?
Female Expert: For me, the core principle is that no one should be denied essential care because of cost. Policies should be judged first on whether they reduce financial barriers, especially for vulnerable groups, even if that means more active government involvement.
Male Expert: And I’d say sustainability. Access today is important, but so is access tomorrow. Policies need to ensure that systems can continue to provide care over time. Ideally, that means combining affordability with incentives that keep supply reliable.
Host: Thank you both. What I’m hearing is not a simple disagreement, but different starting points. There’s shared recognition that pricing affects access, and that poorly designed policies can backfire. The remaining tension is about which principle should lead: immediate affordability or long-term sustainability. That’s a useful place to pause for today.
[REPEAT Part Four]
R: That is the end of Part Four.
R: You will hear part of a University Tutorial about pricing and access.
R: You will hear the discussion twice. Choose the correct answers. You have one minute to read through the questions below.
[beep]
Host: Good afternoon, everyone. In today’s tutorial we’re looking at pricing and access in public health, specifically how the cost of medicines and services affects who actually receives care. With me are Dr Alex Romero, a health economist, and Dr Lila Chen, who works on health equity. I’d like us to explore not only prices themselves, but also the broader impact on access. Alex, could you start us off with your initial view?
Male Expert: Thanks, Helen. I think it’s useful to begin by saying that pricing is not just about profit. From an economic point of view, prices can signal value and help ensure a stable supply. If prices are pushed too low without planning, we may see shortages or reduced innovation. That said, I do accept that high prices can limit access, especially for low-income groups, so the challenge is finding a balance rather than assuming lower prices always solve the problem.
Female Expert: I agree that balance is important, but I’d frame the issue slightly differently. From an equity perspective, the starting point is access. If people can’t afford essential medicines or basic services, the system is failing in its public health role. In many settings, prices are already a barrier, even when supply exists. So while I understand Alex’s concern about sustainability, I think affordability has to come first in policy decisions.
Host: That’s a helpful contrast. Let us move on to the role of governments. Many governments use subsidies or price controls to improve access. Alex, how effective do you think these tools are in practice?
Male Expert: In my view, subsidies can be effective if they’re well targeted. For example, supporting low-income patients directly can improve access without distorting the entire market. Price controls, on the other hand, are more risky. They can work in the short term, but over time they may discourage manufacturers from entering the market. I’m not saying they should never be used, but I’d be cautious and use them alongside other measures.
Female Expert: Can I add to that? I think the evidence shows that carefully designed price regulation doesn’t automatically lead to shortages. In some countries, negotiated pricing has expanded access quite successfully. That may be true, Alex, that poor design causes problems, but the same can be said of subsidies. If subsidies are too complex, the people who need them most may not benefit.
Host: So there seems to be some agreement that design matters. I’d like to pick up on something implicit here: the difference between theoretical outcomes and real-world behaviour. Lila, do you think economic models underestimate social factors?
Female Expert: To some extent, yes. Models are useful, but they don’t always capture how people experience costs. For example, even small fees can discourage care if people are uncertain about future expenses. So when we talk about ‘affordable’, it’s not only the absolute price, but also predictability and trust in the system.
Male Expert: That’s a good point, and I don’t disagree. I’d just add that ignoring costs entirely can also harm trust. If a system becomes financially unstable, patients may lose confidence in its long-term availability. So again, I see this as a trade-off rather than a choice between economics and equity.
Host: We’re coming towards the end, so let me ask one final question. If you had to prioritise one principle for policymakers working on pricing and access, what would it be? Lila?
Female Expert: For me, the core principle is that no one should be denied essential care because of cost. Policies should be judged first on whether they reduce financial barriers, especially for vulnerable groups, even if that means more active government involvement.
Male Expert: And I’d say sustainability. Access today is important, but so is access tomorrow. Policies need to ensure that systems can continue to provide care over time. Ideally, that means combining affordability with incentives that keep supply reliable.
Host: Thank you both. What I’m hearing is not a simple disagreement, but different starting points. There’s shared recognition that pricing affects access, and that poorly designed policies can backfire. The remaining tension is about which principle should lead: immediate affordability or long-term sustainability. That’s a useful place to pause for today.
[REPEAT Part Four]
R: That is the end of Part Four.
1
What is Dr Romero’s initial attitude towards pricing in public health?
2
According to the discussion, why does Dr Chen think affordability should come first?
3
Who suggests that price controls can be risky if used on their own?
4
On which point do Dr Romero and Dr Chen most clearly agree?
5
What does Dr Chen imply about small fees for health services?
6
What is the presenter’s final overall conclusion about the discussion?
Result:
Explanation
{<br> "questions": [<br> {<br> "question": 1,<br> "correct_answer": "B",<br> "why_correct": "This is an <b>attitude</b> question. Dr Romero says prices can signal value and keep supply stable, but he also accepts that high prices limit access. This matches <b>B</b> because he supports pricing, but wants balance with access.",<br> "incorrect_options": {<br> "A": "<b>A</b> is wrong because he warns that very low prices can cause shortages, but we need a balanced view. This is a partial truth trap.",<br> "C": "<b>C</b> is wrong because he clearly says pricing affects supply and access, so it does influence outcomes. This is a context shift trap."<br> },<br> "key_listening_points": [<br> "Listen for how Dr Romero talks about profit and balance",<br> "Notice his careful, balanced tone, not extreme views"<br> ],<br> "paraphrasing": "'finding a balance' = 'necessary tool that must be balanced with access concerns'",<br> "tips": "For attitude questions, listen for feelings and opinions, not just facts.",<br> "transcript_reference": "...Male Expert: Thanks, Helen. I think it’s useful to begin by saying that pricing is not just about profit. <u>From an economic point of view, prices can signal value and help ensure a stable supply. If prices are pushed too low without planning, we may see shortages or reduced innovation. That said, I do accept that high prices can limit access, especially for low-income groups, so the challenge is finding a balance rather than assuming lower prices always solve the problem.</u> Female Expert: I agree that balance is important, but I’d frame the issue slightly differently...."<br> },<br> {<br> "question": 2,<br> "correct_answer": "B",<br> "why_correct": "This is a <b>detail</b> question. Dr Chen says that in many places, prices are already a barrier even when supply exists. This supports <b>B</b> because people cannot access care due to cost.",<br> "incorrect_options": {<br> "A": "<b>A</b> is wrong because she does not talk about who innovation helps. This is a context shift trap.",<br> "C": "<b>C</b> is wrong because she does not say governments are unwilling to regulate. This is a paraphrase confusion trap."<br> },<br> "key_listening_points": [<br> "Listen for Dr Chen’s reasons for putting access first",<br> "Focus on exact reasons she gives, not general ideas"<br> ],<br> "paraphrasing": "'prices are already a barrier' = 'existing prices prevent access'",<br> "tips": "For detail questions, remember the exact reason the speaker gives.",<br> "transcript_reference": "...Female Expert: I agree that balance is important, but I’d frame the issue slightly differently. <u>From an equity perspective, the starting point is access. If people can’t afford essential medicines or basic services, the system is failing in its public health role. In many settings, prices are already a barrier, even when supply exists.</u> So while I understand Alex’s concern about sustainability, I think affordability has to come first in policy decisions...."<br> },<br> {<br> "question": 3,<br> "correct_answer": "C",<br> "why_correct": "This is an <b>attribution</b> question. Dr Romero says price controls are risky and may discourage manufacturers over time. This matches <b>C</b> because he explains the market effects.",<br> "incorrect_options": {<br> "A": "<b>A</b> is wrong because the presenter does not discuss risks in detail. This is an attribution trap.",<br> "B": "<b>B</b> is wrong because Dr Chen argues price controls can work if designed well. This is an attribution trap."<br> },<br> "key_listening_points": [<br> "Track who is speaking when risks are mentioned",<br> "Notice Dr Romero’s cautious language"<br> ],<br> "paraphrasing": "'price controls are more risky' = 'can be risky if used on their own'",<br> "tips": "For attribution questions, always ask: who said this?",<br> "transcript_reference": "...Host: That’s a helpful contrast. Let us move on to the role of governments. Many governments use subsidies or price controls to improve access. <u>Male Expert: In my view, subsidies can be effective if they’re well targeted. For example, supporting low-income patients directly can improve access without distorting the entire market. Price controls, on the other hand, are more risky.</u> They can work in the short term, but over time they may discourage manufacturers from entering the market...."<br> },<br> {<br> "question": 4,<br> "correct_answer": "A",<br> "why_correct": "This is an <b>agreement</b> question. Both speakers say that poor design causes problems and good design helps policies work. This clearly supports <b>A</b>.",<br> "incorrect_options": {<br> "B": "<b>B</b> is wrong because they do not say subsidies are always better. This is a partial truth trap.",<br> "C": "<b>C</b> is wrong because both still value economic models. This is a context shift trap."<br> },<br> "key_listening_points": [<br> "Listen for moments where both speakers agree",<br> "Notice shared phrases like 'design matters'"<br> ],<br> "paraphrasing": "'carefully designed' and 'poor design causes problems' = 'policy design influences success'",<br> "tips": "For agreement questions, compare both speakers, not just one.",<br> "transcript_reference": "...Female Expert: Can I add to that? I think the evidence shows that carefully designed price regulation doesn’t automatically lead to shortages. <u>That may be true, Alex, that poor design causes problems, but the same can be said of subsidies. If subsidies are too complex, the people who need them most may not benefit.</u> Host: So there seems to be some agreement that design matters...."<br> },<br> {<br> "question": 5,<br> "correct_answer": "C",<br> "why_correct": "This is an <b>inference</b> question. Dr Chen says even small fees can discourage care when people feel uncertain. This implies <b>C</b>, that minor costs can still stop people seeking help.",<br> "incorrect_options": {<br> "A": "<b>A</b> is wrong because explanation does not remove fear of future costs. This is a partial truth trap.",<br> "B": "<b>B</b> is wrong because she focuses on patient behaviour, not budgets. This is a context shift trap."<br> },<br> "key_listening_points": [<br> "Listen for examples, not direct answers",<br> "Think about what her example suggests"<br> ],<br> "paraphrasing": "'even small fees can discourage care' = 'minor amounts still stop people'",<br> "tips": "For inference questions, ask what the speaker suggests, not what they say directly.",<br> "transcript_reference": "...Host: I’d like to pick up on something implicit here: the difference between theoretical outcomes and real-world behaviour. Lila, do you think economic models underestimate social factors? <u>Female Expert: To some extent, yes. Models are useful, but they don’t always capture how people experience costs. For example, even small fees can discourage care if people are uncertain about future expenses.</u> So when we talk about ‘affordable’, it’s not only the absolute price, but also predictability and trust in the system...."<br> },<br> {<br> "question": 6,<br> "correct_answer": "A",<br> "why_correct": "This is a <b>conclusion</b> question. The presenter says the tension is about which principle should lead: affordability or sustainability. This matches <b>A</b> exactly.",<br> "incorrect_options": {<br> "B": "<b>B</b> is wrong because the presenter says it is not a simple answer. This is a partial truth trap.",<br> "C": "<b>C</b> is wrong because he does not choose one side as better. This is a paraphrase confusion trap."<br> },<br> "key_listening_points": [<br> "Listen carefully to the final summary",<br> "Notice contrast words like 'not a simple disagreement'"<br> ],<br> "paraphrasing": "'which principle should lead' = 'which should be prioritised first'",<br> "tips": "For conclusion questions, focus on the presenter’s final summary, not earlier opinions.",<br> "transcript_reference": "...Host: Thank you both. What I’m hearing is not a simple disagreement, but different starting points. <u>There’s shared recognition that pricing affects access, and that poorly designed policies can backfire. The remaining tension is about which principle should lead: immediate affordability or long-term sustainability.</u> That’s a useful place to pause for today...."<br> }<br> ]<br>}
With a free account:
Retry and compare every attempt.
Saving...